Lv72
4010 积分 2022-07-07 加入
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors
1个月前
已完结
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization
1个月前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
1个月前
已完结
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer
1个月前
已完结
Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial
1个月前
已完结
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
1个月前
已完结
Circulating tumor DNA as a biomarker in early phase clinical trials
2个月前
已完结
Understanding How Aspirin Prevents Metastasis
2个月前
已完结
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
2个月前
已完结
Eleven clinical trials that will shape medicine in 2026
2个月前
已完结
皖公网安备34019202002308
